Acemannan is a complex polysaccharide obtained from the inner gel of the aloe vera leaf. It is considered as the main functional component of aloe vera.
Acemannan has been extensively studied and was pre-clinically and clinically shown to have many biological benefits.
Acemannan hydrogel’s safety and efficacy are supported by years of publications and clinical studies. To date, there are over 60 peer-reviewed published articles demonstrating Acemannan’s safety and effectiveness.
With an excellent record of over 1 million users with no MHRA or FDA reports Acemannan is a particularly safe substance.
Being a fully integrated company allows us to control the overall value chain from the leaf to our final products.
State-of-the-art processing facilities (GMP).
Full QMS (Quality Management System) including compliance with the FDA requirements for QSR (Quality System Regulation) and ISO 13485.
The Acemannan hydrogel formulation was previously cleared by the FDA and received CE in Europe for Rx and professional use. We are currently renewing all previous approvals and adding OTC options for some of the indications.
We protect our products based on our proprietary technology and knowledge. Our IP are covered in all vertical pillars of our business. For technology IP management, AceTech adheres to a dual strategy of patenting the technology and keeping the software and algorithm as a trade secret.
The manufacturing process of Acemannan is a key factor for obtaining an extract that remains active, maintaining all the beneficial properties of the plant. Our unique and proprietary process uses no heat, thus preserving the full spectrum of complex carbohydrates, which includes Acemannan, virtually bio-identical to fresh aloe vera found in nature.
Other producers of aloe vera worldwide are able to preserve only a tiny portion of the key larger molecules in their products.